Intragastric administration of low-dose rotenone post-colitis exacerbates damage to the nigrostriatal dopaminergic system in Parkinson's disease: The pace accelerates even more
Nishant Sharma, Monika Sharma, Disha Thakkar, Hemant Kumar, Soňa Smetanová, Lucie Burešová, Petr Andrla, Amit Khairnar
This study shows that low-dose rotenone given after colitis worsens gut dysfunction and accelerates dopaminergic neuron loss in a mouse model of Parkinson's disease.
bioRxiv · Dec 22, 2022 · PreprintNeuroscience